A novel artificial intelligence framework improves prediction of mRNA translation efficiency, enhancing the design of mRNA vaccines and therapies for viruses, cancer, and genetic disorders. By forecasting protein expression profiles across cell types and conditions, this technology accelerates drug discovery and optimizes mRNA sequence engineering, representing a significant advance in synthetic biology and precision medicine platforms.